Adult thymus transplantation with allogeneic intra-bone marrow-bone marrow transplantation from same donor induces high thymopoiesis, mild graft-versus-host reaction and strong graft-versus-tumour effects

Immunology

Volumn 126, Issue 4, 2009, Pages 552-564

  Miyake, Takashi ^a   Hosaka, Naoki ^a   Cui, Wenhao ^a   Nishida, Teruhisa ^a   Takaki, Takashi ^a   Inaba, Muneo ^a   Kamiyama, Yasuo ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Graft versus host; Graft versus tumour; Intra bone marrow bone marrow transplantation; Regulatory T cells; Thymopoiesis; Thymus transplantation

Indexed keywords

DNA NUCLEOTIDYLEXOTRANSFERASE; TRANSCRIPTION FACTOR FOXP3;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL INFILTRATION; CELL MATURATION; COMPARATIVE STUDY; CONTROLLED STUDY; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HISTOLOGY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SARCOMA; SPLEEN; SURVIVAL; T LYMPHOCYTE; THYMOPOIESIS; THYMUS TRANSPLANTATION; TUMOR CELL; TUMOR GROWTH; TUMOR REGRESSION;

ANIMALS; APOPTOSIS; BODY WEIGHT; BONE MARROW TRANSPLANTATION; CYTOKINES; FEMALE; GRAFT VS HOST REACTION; GRAFT VS TUMOR EFFECT; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TRANSPLANTATION CHIMERA;

EID: 61449148627     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02920.x     Document Type: Article

References (47)

1. Thomas ED. Landmarks in the development of hematopoietic cell transplantation. World J Surg 2000 24 : 815 8.
2. Bacigalupo A, Oneto R, Bruno B et al. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation. Acta Haematol 2000 103 : 19 25.
3. Chen RL, Hou JW, Chang PY, Tsai FJ, Wang PJ. Matched unrelated bone marrow transplantation without splenectomy for a child with Gaucher disease caused by homozygosity of the L444P mutation, who also suffered from schizencephaly. J Pediatr Hematol Oncol 2007 29 : 57 9.
4. Sato T, Kobayashi R, Toita N, Kaneda M, Hatano N, Iguchi A, Kawamura N, Ariga T. Stem cell transplantation in primary immunodeficiency disease patients. J Pediatr Hematol Oncol 2007 29 : 57 9.
5. Kanamori H, Tanaka M, Kawaguchi H, Yamaji S, Fujimaki K, Tomita N, Fujisawa S, Ishigatsubo Y. Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature. Am J Hematol 2002 71 : 41 4.
6. Saba N, Flaig T. Bone marrow transplantation for nonmalignant diseases. J Hematother Stem Cell Res 2002 11 : 377 87.
7. Ueno NT, Rizzo JD, Demirer T et al. Allogeneic hematopoietic cell transplantation for metastatic breast cancer. Bone Marrow Transplant 2008 41 : 537 45.
8. Kolb HJ, Schattenberg A, Goldman JM et al. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995 86 : 2041 50.
9. Saito TI, Rubio MT, Sykes M. Clinical relevance of recipient leukocyte infusion as antitumor therapy following nonmyeloablative allogeneic hematopoietic cell transplantation. Exp Hematol 2006 34 : 1271 7.
10. Ohmori I, Hayamizu K, Oishi K, Yoshimitsu M, Itamoto T, Asahara T. Inhibition of tumor growth in immunocompromised hosts by restoring type-2 immunity using infusion of G-CSF-treated allogeneic CD8+ leukocytes. Cytokine 2005 32 : 255 62.
11. Russell NH, Byrne JL, Faulkner RD, Gilyead M, Das-Gupta EP, Haynes AP. Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant 2005 36 : 437 41.
12. Chao NJ. Graft-versus-host disease. The view point from the donor T cell. Biol Blood Marrow Transplant 1997 3 : 1 10.
13. Goulmy E, Schipper R, Blokland E, Falkenburg F. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host-disease after bone marrow transplantation. N Engl J Med 1996 334 : 281 5.
14. Murphy WJ, Blazar BR. New strategies for preventing graft-versus-host disease. Curr Opin Immunol 1999 11 : 509 15.
15. Hosaka N, Nose M, Kyogoku M, Nagata N, Miyashima S, Good RA, Ikehara S. Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+mice. Proc Natl Acad Sci USA 1996 93 : 8558 62.
16. Kushida T, Inaba M, Takeuchi K, Sugiura K, Ogawa R, Ikehara Y. Treatment of intractable autoimmune disease in MRL/lpr mice using a new strategy for allogeneic bone marrow cells transplantation. Blood 2000 95 : 1862 8.
17. Kushida T, Inaba M, Hisha H, Ichioka N, Esumi T, Ogawa R, Iida H, Ikehara S. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 2001 97 : 3292 9.
18. Nakamura K, Inaba M, Sugiura K, Yoshimura T, Kwon AH, Kamiyama Y, Ikehara S. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of graft-versus-host diseases (GvHD) by intra-bone marrow-bone marrow transplantation plus donor lymphocyte infusion. Stem Cells 2004 22 : 125 34.
19. Hashimoto F, Sugiura K, Inoue K, Ikehara S. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 1997 89 : 49 54.
20. Sugiura K, Hisha H, Ishikawa J, Adachi Y, Taketani S, Lee S, Nagahama T, Ikehara S. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro. Stem Cells 2001 19 : 46 58.
21. Ikehara S. A novel strategy for allogeneic stem cell transplantation: perfusion method plus intra-bone marrow injection of stem cells. Exp Hematol 2003 31 : 1142 6.
22. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002 99 : 3838 43.
23. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, Ringdén O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004 363 : 1439 41.
24. Moore NC, Anderson G, Smith CA, Owen JJ, Jenkinson EJ. Analysis of cytokine gene expression in subpopulations of freshly isolated thymocytes and thymic stromal cells using semiquantitative polymerase chain reaction. Eur J Immunol 1993 23 : 922 7.
25. Bodey B, Bodey B Jr., Siegel SE, Kaiser HE. Review of thymic hormones in cancer diagnosis and treatment. Int J Immunopharmacol 2000 22 : 261 73.
26. Ziegler SF, Liu YJ. Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 2006 7 : 709 14.
27. Sakaguchi S, Ono M, Setoguchi R et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006 212 : 8 27.
28. Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL, Cohen JL. Recipient-type specific CD4+ CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003 112 : 1688 96.
29. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS. CD4+ CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003 9 : 1144 50.
30. Hosaka N, Ryu T, Miyake T, Cui W, Nishida T, Takaki T, Inaba M, Ikehara S. Treatment of autoimmune diseases in MRL/lpr mice by allogeneic bone marrow transplantation plus adult thymus transplantation. Clin Exp Immunol 2007 147 : 555 63.
31. Ryu T, Hosaka N, Miyake T et al. Transplantation of newborn thymus plus hematopoietic stem cells can rescue supralethal irradiated mice. Bone Marrow Transplant 2008 41 : 659 66.
32. van den Brink MR, Alpdogan O, Boyd RL. Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat Rev Immunol 2004 4 : 856 67.
33. Markert ML, Boeck A, Hale LP, Kloster AL, McLaughlin TM. Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med 1999 341 : 1180 9.
34. Markert ML, Hicks CB, Bartlett JA, Harmon JL. Hale Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. AIDS Res Hum Retroviruses 2000 16 : 403 13.
35. Hill GR, Cooke KR, Teshima T, Crawford JM, Keith JC Jr., Brinson YS, Bungard D, Ferrara JL. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J Clin Invest 1998 102 : 115 23.
36. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997 90 : 3204 13.
37. Hosaka N, Minato T, Yoshida S, Toki J, Yang G, Hisha H, Ikehara S. Kimura's disease with unusual eosinophilic epithelioid granulomatous reaction: a finding possibly related to eosinophil apoptosis. Hum Pathol 2002 33 : 561 4.
38. Hosaka N, Kitajiri S, Hiraumi H, Nogaki H, Toki J, Yang G, Hisha H, Ikehara S. Ectopic pituitary adenoma with malignant transformation. Am J Surg Pathol 2002 26 : 1078 82.
39. Sempowski GD, Gooding ME, Liao HX, Le PT, Haynes BF. T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol Immunol 2002 38 : 841 8.
40. Takada K, Inaba M, Ichioka N et al. Treatment of senile osteoporosis in SAMP6 mice by intra-bone marrow injection of allogeneic bone marrow cells. Stem Cells 2006 24 : 399 405.
41. - donor lymphocyte infusion. Stem Cells 2005 23 : 365 70.
42. Miura Y, Thoburn CJ, Bright EC, Arai S, Hess AD. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 2004 104 : 2187 93.
43. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002 196 : 389 99.
44. Hoffmann P, Edinger M. CD4+ CD25+ regulatory T cells and graft-versus-host disease. Semin Hematol 2006 43 : 62 9.
45. Sakaguchi S. Taming transplantation with T cells. Nat Med 2003 9 : 1117 8.
46. Cui W, Hosaka N, Miyake T et al. Analysis of tolerance induction using triple chimeric mice: MHC-disparate thymus, hemopoietic cells and microenvironment. Transplantation 2008 85 : 1151 8.
47. Zhang L, Sun L, Zhao Y. Thymic epithelial progenitor cells and thymus regeneration: an update. Cell Res 2007 17 : 50.